TGFB1 and colorectal carcinoma: Studies have demonstrated that weight loss is associated with a reduction in the levels of inflammatory markers such as TGFβ, TNFα, IL‐6, interleukin 18 (IL‐18), MCP‐1, C‐reactive protein (CRP), and leptin, which are known to contribute to CRC development.1, 279